Schellekens, Huub
4 papers on CoChatORCID 0000-0002-8503-3965
Most cited papers
- Verified
Immunogenicity of therapeutic proteins: the use of animal models
Brinks, V., Jiskoot, W., & Schellekens, H. (2011) · Pharmaceutical Research
Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research
Cited by 164
- Verified
Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity
Yang, Y., Liu, F., Franc, V., Halim, L. A., Schellekens, H., & Heck, A. J. R. (2016) · Nature Communications
Glycosylation and Glycoproteins ResearchMass Spectrometry Techniques and Applications
Cited by 152
- Verified
The ability of animal studies to detect serious post marketing adverse events is limited
van Meer, P. J. K., Kooijman, M., Gispen-de Wied, C. C., Moors, E. H. M., & Schellekens, H. (2012) · Regulatory Toxicology and Pharmacology
Animal testing and alternativesPharmacovigilance and Adverse Drug Reactions
Cited by 66
- Verified
Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development
Ferreira, G. S., Veening-Griffioen, D. H., Boon, W. P. C., Moors, E. H. M., Gispen-de Wied, C. C., Schellekens, H., & van Meer, P. J. K. (2019) · PLOS ONE
Animal testing and alternativesStatistical Methods in Clinical Trials
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free